News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ALR Technologies Inc. Entry Into a Material Definitive Agreement With PARI Respiratory Equipment, Inc.



9/22/2009 10:39:08 AM

ATLANTA, GA--(Marketwire - September 22, 2009) - ALR Technologies (OTCBB: ALRT) announced in an 8K filing that on September 18, 2009, that Pari Respiratory Equipment, Inc. and ALR Technologies Inc. signed an agreement in which ALR Technologies licensed the Company's patented nebulizer compressor monitoring technology to Pari Respiratory Equipment, Inc. for the manufacturing and marketing of compliance-ready monitoring nebulizers worldwide.

About ALR Technologies Inc.

The ALRT Health-E-Connect Disease Management System is designed to enhance compliance of prescribed therapies and report diagnostic data from a number of devices to health professionals for monitoring of patients. The System facilitates cost effective continued oversight and care plan evaluation of patients by authorized health professionals in-between visits to their physician. More information on ALR Technologies and its products can be found at http://www.alrt.com.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.


Public Relations:
678-881-0002 Ext. 704
e-mail: Email Contact


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES